http://purl.org/np/RA1343SbM4Wqjs8cyjrcWdsI1OZCIog8tty3jmM1UJF7A#Head
http://purl.org/np/RA1343SbM4Wqjs8cyjrcWdsI1OZCIog8tty3jmM1UJF7A
http://www.nanopub.org/nschema#hasAssertion
http://purl.org/np/RA1343SbM4Wqjs8cyjrcWdsI1OZCIog8tty3jmM1UJF7A#assertion
http://purl.org/np/RA1343SbM4Wqjs8cyjrcWdsI1OZCIog8tty3jmM1UJF7A
http://www.nanopub.org/nschema#hasProvenance
http://purl.org/np/RA1343SbM4Wqjs8cyjrcWdsI1OZCIog8tty3jmM1UJF7A#provenance
http://purl.org/np/RA1343SbM4Wqjs8cyjrcWdsI1OZCIog8tty3jmM1UJF7A
http://www.nanopub.org/nschema#hasPublicationInfo
http://purl.org/np/RA1343SbM4Wqjs8cyjrcWdsI1OZCIog8tty3jmM1UJF7A#pubinfo
http://purl.org/np/RA1343SbM4Wqjs8cyjrcWdsI1OZCIog8tty3jmM1UJF7A
http://www.w3.org/1999/02/22-rdf-syntax-ns#type
http://www.nanopub.org/nschema#Nanopublication
http://purl.org/np/RA1343SbM4Wqjs8cyjrcWdsI1OZCIog8tty3jmM1UJF7A#assertion
http://purl.obolibrary.org/obo/DOID_3973
https://w3id.org/biolink/vocab/category
https://w3id.org/biolink/vocab/Disease
http://purl.org/np/RA1343SbM4Wqjs8cyjrcWdsI1OZCIog8tty3jmM1UJF7A#association
http://www.w3.org/1999/02/22-rdf-syntax-ns#object
http://purl.obolibrary.org/obo/DOID_3973
http://purl.org/np/RA1343SbM4Wqjs8cyjrcWdsI1OZCIog8tty3jmM1UJF7A#association
http://www.w3.org/1999/02/22-rdf-syntax-ns#predicate
https://w3id.org/biolink/vocab/treats
http://purl.org/np/RA1343SbM4Wqjs8cyjrcWdsI1OZCIog8tty3jmM1UJF7A#association
http://www.w3.org/1999/02/22-rdf-syntax-ns#subject
https://identifiers.org/drugbank:DB06655
http://purl.org/np/RA1343SbM4Wqjs8cyjrcWdsI1OZCIog8tty3jmM1UJF7A#association
http://www.w3.org/1999/02/22-rdf-syntax-ns#type
http://www.w3.org/1999/02/22-rdf-syntax-ns#Statement
http://purl.org/np/RA1343SbM4Wqjs8cyjrcWdsI1OZCIog8tty3jmM1UJF7A#association
http://www.w3.org/2000/01/rdf-schema#label
"* Medullary Thyroid Carcinoma VICTOZA is contraindicated in patients with a personal or family history of medullary thyroid carcinoma (MTC) or in patients with Multiple Endocrine Neoplasia syndrome type 2 (MEN 2). * Hypersensitivity VICTOZA is contraindicated in patients with a prior serious hypersensitivity reaction to VICTOZA or to any of the product components. Serious hypersensitivity reactions including anaphylactic reactions and angioedema have been reported with VICTOZA [see Warnings and Precautions 5.6 VICTOZA is contraindicated in patients with a personal or family history of medullary thyroid carcinoma or in patients with Multiple Endocrine Neoplasia syndrome type 2 (4) VICTOZA is contraindicated in patients with a prior serious hypersensitivity reaction to VICTOZA or any of the product components (4)"
http://purl.org/np/RA1343SbM4Wqjs8cyjrcWdsI1OZCIog8tty3jmM1UJF7A#association
https://w3id.org/biolink/vocab/provided_by
https://w3id.org/um/NeuroDKG
http://purl.org/np/RA1343SbM4Wqjs8cyjrcWdsI1OZCIog8tty3jmM1UJF7A#association
https://w3id.org/biolink/vocab/relation
https://schema.org/MedicalContraindication
https://identifiers.org/drugbank:DB06655
https://w3id.org/biolink/vocab/category
https://w3id.org/biolink/vocab/Drug
http://purl.org/np/RA1343SbM4Wqjs8cyjrcWdsI1OZCIog8tty3jmM1UJF7A#provenance
http://purl.org/np/RA1343SbM4Wqjs8cyjrcWdsI1OZCIog8tty3jmM1UJF7A#assertion
http://www.w3.org/ns/prov#wasAttributedTo
https://orcid.org/0000-0002-1468-3557
http://purl.org/np/RA1343SbM4Wqjs8cyjrcWdsI1OZCIog8tty3jmM1UJF7A#pubinfo
http://purl.org/np/RA1343SbM4Wqjs8cyjrcWdsI1OZCIog8tty3jmM1UJF7A#sig
http://purl.org/nanopub/x/hasAlgorithm
RSA
http://purl.org/np/RA1343SbM4Wqjs8cyjrcWdsI1OZCIog8tty3jmM1UJF7A#sig
http://purl.org/nanopub/x/hasPublicKey
MIGfMA0GCSqGSIb3DQEBAQUAA4GNADCBiQKBgQCODwZkXojpEKwk7Ldj2oPPfCstvqrcpgCaTLo235K7ht9C7E1GCkLvUuL2b4VWXJTcZx/hxgDauR8hUeYq/lS6tfTL9yFZsnfl+PWYDyz7vv6N+wJVx2LL8bO6ntCjcOzvW2t2WUeF12Sb6b3I6uOYP0N8iQKts1WasY/yEYKAHQIDAQAB
http://purl.org/np/RA1343SbM4Wqjs8cyjrcWdsI1OZCIog8tty3jmM1UJF7A#sig
http://purl.org/nanopub/x/hasSignature
d9Vlfp1Vf1jxuIUpZILvARde79XAv+EnBWP3LJAqM2F1QeU2FO/JoIHztX8vACMkq1yUE/RPp1OQpoiL9WtGwokAvKeg+5xcq1AWXHJlapZvfP6rJmCMXFxpb1AUxK6O9ecjj2uEkXGZp8/8cHE406TVAaYYRWsFrwkYLRqnuFY=
http://purl.org/np/RA1343SbM4Wqjs8cyjrcWdsI1OZCIog8tty3jmM1UJF7A#sig
http://purl.org/nanopub/x/hasSignatureTarget
http://purl.org/np/RA1343SbM4Wqjs8cyjrcWdsI1OZCIog8tty3jmM1UJF7A
http://purl.org/np/RA1343SbM4Wqjs8cyjrcWdsI1OZCIog8tty3jmM1UJF7A
http://purl.org/dc/terms/created
2021-08-23T19:14:26.265+02:00
http://purl.org/np/RA1343SbM4Wqjs8cyjrcWdsI1OZCIog8tty3jmM1UJF7A
http://purl.org/dc/terms/creator
https://orcid.org/0000-0002-1468-3557
http://purl.org/np/RA1343SbM4Wqjs8cyjrcWdsI1OZCIog8tty3jmM1UJF7A
https://w3id.org/np/o/ntemplate/wasCreatedFromProvenanceTemplate
http://purl.org/np/RANwQa4ICWS5SOjw7gp99nBpXBasapwtZF1fIM3H2gYTM
http://purl.org/np/RA1343SbM4Wqjs8cyjrcWdsI1OZCIog8tty3jmM1UJF7A
https://w3id.org/np/o/ntemplate/wasCreatedFromPubinfoTemplate
http://purl.org/np/RAA2MfqdBCzmz9yVWjKLXNbyfBNcwsMmOqcNUxkk1maIM
http://purl.org/np/RA1343SbM4Wqjs8cyjrcWdsI1OZCIog8tty3jmM1UJF7A
https://w3id.org/np/o/ntemplate/wasCreatedFromTemplate
http://purl.org/np/RAhNHZw6Urw_Mccs4qy6Ws3C9CRuaHpQx8AwuApbWkqnY